Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity

Fig. 6

Toxicity study after multi-dosage. a Body weight change after multi-dosage with DOX, FRRG-DOX or F68-FDOX. b The hematological analyses on day 7 after multi-dosage with DOX, FRRG-DOX or F68-FDOX. c Major organ tissues stained with H&E on day 7 after multi-dosage with DOX, FRRG-DOX or F68-FDOX. Significance was determined by Tukey−Kramer post-hoc test

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us